We studied the effects of a hypocaloric diet with or hepatic secretion rate of VLDL apoB, as well as a without a serotonergic agonist (dexfenfluramine, significant increase (p<0.05) in post-ischaemic flow Df) on the hepatic secretion of very-low-densitydebt repayment. With diet plus Df, there were parallipoprotein (VLDL) apoB and endothelial function of lel responses in these variables, but only decreased the forearm microcirculation in 20 viscerally obese forearm vascular resistance (p<0.05) was statisticmen. The kinetics of VLDL apoB were studied using ally significant. Combining both data sets, there was an infusion of 1-(13C)-leucine. Isotopic enrichment of a highly significant reduction in hepatic apoB apo B was measured using gas-chromatography mass secretion rate (20.9±2.0 vs. 14.7±1.6 mg/kg fat-free spectrometry, and a multicompartmental model was mass/day, p=0.005), as well as an increase in used to estimate kinetic functions. Forearm vasoboth maximal forearm blood flow (16.8±7.5 vs. dilatation was measured following an ischaemic 22.2±8.5 ml/100 ml/min, p=0.006) and flow debt stimulus using strain-gauge plethysmography, and repayment (3.5±2.1 vs. 5.4±2.8 ml/100 ml, p= visceral adipose tissue mass using magnetic resonance 0.01), and a decrease in vascular resistance (6.7±3.7 imaging. Compared with leaner subjects, the obese vs. 5.1±4.4 mmHg/ml/100 ml/min, p=0.007). men had significantly higher hepatic apoB secretion Obese men have increased hepatic secretion of apoB (p<0.05) and lower forearm flow debt repayment and endothelial dysfunction of the forearm microcir-(p<0.001). Both treatments produced similar culation, and decreasing their visceral adipose tissue decreases (p<0.05) in body weight, waist circumfermass by diet (with or without a serotonergic agonist) ence, visceral adipose tissue and fasting plasma insuimproves these abnormalities. This may provide a lin. With diet alone, there was a significant decrease mechanistic basis for the reduction in cardiovascular (p<0.05) in the plasma concentration and pool size risk in obese patients who lose weight.
Introduction
Visceral obesity increases the risk of cardiovascular osis, may also co-exist with visceral adiposity.4,5 No previous studies have investigated whether these disease, possibly owing to insulin resistance, hypertension and dyslipidaemia,1 but the precise mechanabnormalities are reversible by reducing visceral fat. ApoB is constitutively expressed in human liver, isms remain undefined. We have previously shown that hepatic output of apolipoprotein B-100 (apoB), and its metabolism is regulated post-translationally by the availability of lipid substrates.6 Abdominal a determinant of the plasma concentrations of atherogenic lipoproteins,2 is elevated in visceral obesity. 3 adipocytes have a high lipolytic capacity that increases the flux of free fatty acids to the liver.7 Endothelial dysfunction, a precursor of atheroscler-This enhances the supply of neutral lipids necessary on a 1600 kcal reduced-fat diet (25% of energy from fat). After a 4-week run-in on an isocaloric diet, for hepatic assembly and secretion of VLDL apoB, 8 patients were randomized to Df or placebo for 3 that may be quantified in vivo using endogenous months. During treatment, patients received one labelling of apoB with a stable isotope. 9 Increased capsule (15 mg Df or placebo) with the evening hepatic synthesis of neutral lipids is associated with meal for 1 week at the beginning of the treatment oversecretion of apoB measured by this technique.3, 9 period and then one capsule (15 mg Df or placebo) Insulin resistance may also contribute directly to with breakfast, and one capsule with the evening abnormal apoB metabolism. 10 meal for the next 11 weeks. Tablet compliance was Endothelial dysfunction is an early feature of checked by tablet count. Patients were reviewed vascular damage due to abnormal release of vasoacmonthly. At the end of 3 months, baseline measuretive agents, in particular nitric oxide (NO), that ments were repeated. control arterial tonicity, thrombogenesis and mitogenesis.11 Endothelial dysfunction is seen in visceral obesity4,5 and may be due to elevated plasma levels Clinical protocol of fatty acids,12 small dense LDL or apoB, 13 
or to
Clinical tests insulin resistance.14 A simple in vivo test of endothelial function is the plethysmographic measurement of Weight and height were measured without shoes post-ischaemic flow-mediated dilatation of peripheral and in light clothing. Body mass index (BMI) (kg/m2) resistance vessels. 15 was calculated. Waist circumference (cm) was measDexfenfluramine (Df), the D-enantiomer of fenflurured at the point midway between the costal margin amine, is effective pharmacotherapy for weight loss and iliac crest in the mid-axillary line. Hip circumferin obese subjects. 16 It decreases appetite centrally ence (cm) was measured at the widest point around through inhibition of serotonin uptake in presynaptic the greater trochanter. A bioelectrical impedance neurons,17 and directly stimulates fatty acid oxidamethod using a Holtain Body Composition Analyser tion. 18 Df decreases visceral fat and improves insulin (Holtain Ltd) was used to estimate fat mass (FM) and resistance, elevated plasma free fatty acid levels and fat free mass (FFM); this technique correlates well dyslipidaemia. 19 Because of serotonergic actions that with underwater weighing and in our hands has an stimulate the endothelial release of NO,20 Df may imprecision of <5%. To assess glucose tolerance, a also improve endothelial function in coronary arterial 75 g oral load of dextrose in 200 ml water was taken beds. The independent effects of Df, or other seroin the morning after a 14-h fast. Blood samples were tonergic agonists, in the setting of dietary energy collected through a venous cannula from an anterestriction on the increased hepatic output of apoB cubital vein at 0 and 120 min for plasma glucose and endothelial dysfunction in visceral obesity, have and insulin assays. Insulin resistance was assessed not been previously investigated.
from the fasting plasma insulin and glucose concentrations using the homeostasis model.21
Nutritional methods

Methods
For 4 weeks prior to randomization, patients con-
Patients and study design sumed a weight maintenance diet. During this period, body weight did not vary by more than 3%. Subjects Patients (all male) with visceral obesity (BMI completed a 7-day food intake record at weeks 0, Á30 kg/m2, waist-to-hip ratio Á0.99, waist circum-4, 8 and 12. These were subsequently analysed by ference Á100 cm) and dyslipidaemia (fasting a dietitian using DIET4 Nutrient Calculation Software plasma triglyceride Á1.5 mmol/l and HDL choles-(Xyris Software) based on the Australian Food terol ∏1.2 mmol/l) were studied. None had diabetes Composition Database (NUTTAB 95, Australian mellitus, genetic hyperlipidaemia, hepatic disease, Government Nutrient Database). The prescribed proteinuria, or hypothyroidism, or had been treated weight loss diet provided 1600 kcal/day, with with Df or other appetite suppressants. They were approximately 25% from fat. Patients were reviewed not taking medication known to affect plasma lipids, monthly to assess compliance with diet. They were and none were smokers or gave a family history of instructed not to change physical activity during the hyperlipidaemia or coronary disease. The plasma study. Energy expenditure was estimated by a transport rate of VLDL apoB and endothelial function standard 7-day recall questionnaire.22 of the forearm microcirculation in the obese subjects was compared with a group of age-matched Magnetic resonance imaging lean men. The study was approved by the Ethics Committee at Royal Perth Hospital.
At weeks 0 and 12, a magnetic resonance imaging The study design was a randomized double-blind (MRI) scan and glucose tolerance test was carried out. A 1.0 T MR scanner (Picker International) was study comparing Df and placebo in obese subjects used to obtain 10 transverse axial images (field of 40 mmHg above systolic blood pressure for 4 min. After releasing the cuff, blood flow was measured at view 40-48 cm, 10 mm thick) at various intervertebral levels from T10 to the pubis. Subjects lay supine 1-min intervals until flow returned to baseline. Forearm blood flow was calculated by selection of in the magnet field, with arms placed straight above the head and to reduce errors caused by respiratory the steepest gradient of each blood flow curve. The initial peak after ischaemia was defined as the movements, the scans were obtained after quiet exhalation. The data for subcutaneous and visceral maximal hyperaemic response (ml/100 ml of forearm/min). Flow debt repayment was defined as the adipose tissue area from these intervertebral levels were calculated using software developed within the area under the blood flow curve (ml/100 ml of forearm), equivalent to the excess blood flow during MRI department. For the purposes of this study, MRI measurements at the 4th lumbar vertebra (L4) were hyperaemia; the area under the curve was calculated using non-linear regression with the Prism statistical employed to define visceral fat.3 package. Minimum forearm vascular resistance was calculated as mean arterial blood pressure divided
Stable isotope test of apoB kinetics
by maximal blood flow. Forearm length (I) and All patients fasted for at least 14 h and were allowed circumference (c) were measured before and after water only. Venous blood was collected for measureweight reduction; forearm volume was calculated as ment of plasma concentrations of total cholesterol, (c2×I)/4p, assuming the forearm to be shaped like triglycerides, HDL cholesterol, free fatty acids and a circular cylinder. Within-observer coefficient of assessment of apolipoprotein E genotype. A Teflon variation for forearm blood flow responses was cannula was placed into a superficial vein of the left <3%. antecubital fossa, and 1-[13C]-leucine (99.5% enrichment) (Tracer Technologies) was administered by a primed (1 mg/kg), constant (1 mg/kg/h) intravenous
Biochemical methods infusion (10 h duration). Venous blood was collected
Isolation and measurement of isotopic via a cannula from the contralateral arm to measure enrichment of VLDL apoB the isotopic enrichment of apoB, plasma leucine and VLDL apoB concentration.
A 3 ml aliquot of plasma was overlaid with 1.6 ml Plasma volume (litres) was measured using a sodium chloride solution (d=1.006 kg/l), and the standard isotopic dilution technique. Patients were samples were ultracentrifuged for 16 h at 147 000 g injected with 125I albumin (0.00185 mBq/kg body (Centrikon T-1190, Kontron Instruments). The isoproweight) and four blood samples were taken at 10-min panol method was used to precipitate the apoB.3 In intervals. The ratio of 125I albumin administered to our hands, this technique is highly specific for the activity of 125I per litre was plotted against time, apoB-100, and is positively associated with VLDL and plasma volume at time 0 was extrapolated. apoB concentration measured by immunoturbidimetry (r=0.89, p<0.001, n=27). The precipitate was delipidated with ether ethanol (153 v/v), dried and
Post-ischaemic vasodilatation of the forearm
hydrolysed. The amino acids were isolated by cationmicrocirculation exchange chromatography and eluted using 2 ml of This was measured before and after weight reduction, 3M ammonia. The samples were derivatized using and within 1 week of the stable isotope studies.
N -methyl -N -(tert -butyldimethylsilyl) -trifluoroacetSubjects were studied after 10 min rest in a supine amide in acetonitrile, and reconstituted in decane position in a quiet room with ambient temperature for gas chromatography-mass spectrometry (GCMS) controlled at 24°C, and after a 14-h fast. Heart rate analysis (Hewlett Packard 5890). Selected ion monand blood pressure were measured automatically itoring of derivitized samples at a mass-to-charge using a Dinamap, Vital Signs Monitor 1846 SX.
ratio (m/z) of 303 and 302, and using electronMeasurement of forearm blood flow in the left arm impact ionization, was used to determine isotopic was carried out using venous occlusion plethysmogenrichment. Leucine enrichment was calculated raphy with mercury-in-silastic strain gauges placed using the formula:23 5 cm below the antecubital crease (Hokansson, EC4 Plethysmograph connected Maclab/4e, AD
To isolate the forearm blood flow, the wrist cuffs were inflated to 200 mmHg during measurement periods. The upper arm cuff was inflated to where R t is the 13C/12C ratio at time t and R O is 13C/12C ratio at baseline prior to the infusion of 40 mmHg to impede venous outflow but allow arterial inflow. The cuffs were set to inflate for 10 s post-treatment data were compared with control (CV <7.0%). Plasma glucose concentration was groups of age, sex-matched, lean men who were determined by an enzymic hexokinase reaction non-smokers (mean age 46±2.4 years, BMI method using a Technicon Axon analyser (Bayer 25±1.4 kg/m2, cholesterol 5.2±0.6 mmol/l, triDiagnostics) (CV <3.1%). An enzymatic colorimetglyceride 1.1±0.5 mmol/l). Table 1 shows the ric assay was used to determine the concentration anthropometric characteristics before and after of free fatty acids (CV <3.0%).
weight reduction with the hypocaloric diet and the hypocaloric diet plus Df. In both groups, there was a significant decrease ( p<0.001) in body weight,
Calculation of VLDL apoB turnover rate BMI, waist circumference, waist-to-hip ratio, fat mass and visceral adipose tissue area at L4. Of the subjects Z(t) was used to analyse tracer kinetics.23 This was on placebo, six were apolipoprotein E3/E3 homozyderived from enrichment data according to the gotes and four were E4/E3 heterozygotes; one refused equation:
genetic tests. Of the subjects on Df, one was E4/E4 homozygote, six were E3/E3 homozygotes and two
were E4/E3 heterozygotes. The frequency distributions of apolipoprotein E genotypes were not significantly different between the groups. where E(t) is the isotopic enrichment of VLDL apoB at time t, and E(I) is the isotopic enrichment of the With diet alone, there was a significant reduction in total energy intake (2600±256 kcal vs. infusate. A multi-compartmental model was used to analyse the data. SAAM-II (SAAM Institute, University 1846±149 kcal, p=0.002) and percentage of energy from fat (37.3±1.6% vs. 29.8±2.3%, of Washington, Seattle) was used to fit the model to the data and the fractional secretion rate (FSR) of p=0.004), and a significant increase in percentage energy from carbohydrate (42.5±2.0% vs. VLDL apoB (pools/day), equivalent to the fractional catabolic rate (FCR) at steady state concentration, 47.7±2.1%, p=0.021). With diet plus Df, there was also a significant reduction in total energy intake was calculated. The model consisted of three compartments.
(2969±314 kcal vs. 1937±121 kcal, p=0.008) and percentage of energy derived from fat Compartment 1 is a plasma leucine compartment in which 13C enrichment of plasma leucine was used (33.9±1.8% vs. 28.0±1.4%, p=0.05), and a significant increase in the percentage of energy from as the forcing function for the precursor pool in the liver; compartment 2 is an adjustable intrahepatic protein (15.9±1.1% vs. 19.8±1.1%, p=0.004); dietary intakes were not significantly different delay compartment for the assembly and secretion of apoB; and compartment 3 is a plasma compartbetween groups. There were no significant group differences in the level of physical activity before ment for VLDL apoB secreted by the liver. This model is based on the following assumptions:
and after weight reduction. Table 2 shows the biochemical characteristics of (i) patients were in a metabolic steady state throughout the study; (ii) plasma leucine was the source of the patients studied. The plasma cholesterol and triglyceride concentrations were significantly higher the leucine that was incorporated into apoB; and (iii) all apoB entered the plasma via VLDL particles. than in the lean group ( p=0.019 and p=0.006, respectively). At week 0, the data did not differ The absolute secretion rate of VLDL apoB was determined by multiplying FSR and pool size. Pool significantly between the two groups. With diet alone, there was a significant decrease in the size was determined as the product of plasma volume and the mean plasma VLDL apoB concentration. plasma concentrations of cholesterol, triglyceride, and insulin; this was associated with an improvement diet alone there was a significant decrease in VLDL apoB concentration, pool size and hepatic secretion in insulin resistance and an increase in HDL cholesterol. With Df, there was also a significant decrease rate, but no significant alteration in fractional catabolism. With Df, there were parallel changes in VLDL in plasma cholesterol, insulin and free fatty acids. The lipid composition of VLDL did not alter significapoB metabolism, but the differences just failed to reach statistical significance. The within-group antly with weight reduction in either group, but the cholesterol5apoB ratio of VLDL increased with Df. changes in apoB metabolism did not differ between the two treatments. After pooling data from both The tracer-to-tracee curves for plasma leucine and VLDL apoB in the two groups were similar before groups, there was a significant decrease in the plasma concentration (83.5±9.2 vs. 63.7±5.6 mg/l, p= and after weight reduction. Representative curves for the dietary intervention group alone are shown in 0.015), pool size (9295.1±33.0 vs. 225.7±20.0 mg, p=0.014) and hepatic secretion (20.9±2.0 vs. Figure 1 . In all patients, the tracer-to-tracee ratios of plasma leucine reached steady state within 30 min, 14.7±1.6 mg/kg fat-free mass/day, p=0.005) of VLDL apoB. There were no significant correlations and this was sustained throughout the entire infusion period.
between the changes in hepatic secretion rate of VLDL apoB and any of the anthropometric, nutri- Table 3 shows the metabolic parameters and VLDL apoB kinetics. At week 0, both treatment groups had tional or biochemical variables measured. Compared with a retrospective group of 11 obese men studied similar plasma concentrations, fractional catabolic rates and hepatic secretion rates of VLDL apoB, even twice while receiving a weight maintenance diet for 3 months, hepatic secretion of apoB fell significantly though patients in the Df-treated group were heavier and more viscerally obese. Compared with a group more with both interventions (change −6.2±1.9 vs. 6.4±4.9 mg/FFM/day, p=0.034). Postof 16 lean controls, the obese men had significantly higher hepatic secretion of VLDL apoB (20.9±2.0 intervention hepatic apoB secretion was also not significantly different from the lean controls. vs. 14.8±1.8 mg/kg FFM/day, p=0.015). With Table 4 shows the haemodynamic and forearm of 19 lean men. Maximal forearm flow and flow debt repayment in the obese patients at baseline was blood flow data before and after weight reduction with diet and diet plus Df. The volunteers were not significantly impaired compared with the lean controls (16.8±1.7 vs. 23.2±1.7, p=0.012; 3.5± hypertensive. Blood pressure, heart rate, forearm volume and basal blood flow were similar in both 0.4 vs. 17.1±1.4, p<0.001, respectively). Postischaemic maximal forearm blood flow was similar treatment groups and did not alter significantly with weight loss. Basal blood flow in the obese patients in both the obese groups and increased by approximately 25% with weight reduction, but within-group was not significantly different from that in a group changes just failed to reach conventional statistical for having dyslipidaemia,3 and that this is reversible significance. Flow debt repayment increased in both with a degree of weight reduction comparable to groups, the difference being significant only with that achieved in the present study.24 Improvement in diet-induced weight loss. There were parallel changes hepatic apoB secretion was probably a consequence in these variables with Df, but only the decrease in of reduction in both lipid substrate supply to the forearm vascular resistance was significant. When liver6,8 and insulin resistance,10 resulting from loss data were pooled, weight loss was associated with of visceral adipose tissue mass.7,25 This may explain a significant increase in both maximal forearm blood the hypolipidaemic effect of weight reduction. Df flow (p=0.006) and flow debt repayment (p=0.01) has previously been shown to increase fatty acid and with a decrease in forearm vascular resistance oxidation,18 which may account for the significantly (p=0.007) (Figure 2) . However, the flow debt repaylower plasma concentrations of free fatty acids demment following weight loss remained significantly onstrated here. This did not, however, translate into lower than the lean group ( p<0.01). The changes a statistically significant decrease in hepatic apoB in basal and maximal blood flow, flow debt repaysecretion. If the 13% lower hepatic secretion of apoB ment and vascular resistance were not significantly with Df reflects a true population effect of Df in the correlated with the changes in fat mass, plasma setting of a hypocaloric diet, one would need to lipids, lipoproteins or insulin concentrations, or heprandomize 120 patients to test the null hypothesis atic secretion of apoB.
with 80% power at the 5% level of significance. This may not be a clinically relevant study, however, given that both the interventions tested decreased Discussion hepatic apoB secretion into the reference range for lean subjects. The principal finding was that weight reduction of This is the first attempt at using post-ischaemic the order of 5% following a diet with or without Df dilatation of the forearm as a measure of endothelial improved both hepatic secretion of VLDL apoB and function in an intervention trial in viscerally obese peripheral microcirculatory function in men with subjects. Several mediators may contribute to postvisceral obesity. To formally test the hypothesis that ischaemic forearm hyperaemia, including local metaDf achieves greater improvement in these endpoints bolites, adenosine, prostaglandins and NO. NO may than a diet alone would have required a larger be particularly more important in determining flowsample size. The results of this pilot study are debt repayment than maximal blood flow.15 Forearm nevertheless valuable, since they are consistent with vasotonic responses may potentially reflect changes the hypothesis that in visceral obesity weight reducin the coronary circulation.26 The partial restoration tion improves hepatic output of atherogenic lipoproin vasodilatory function noted with weight loss could teins and vascular dysfunction as a consequence of be attributable partly to increased bioavailability of decreases in insulin resistance and lipid substrate NO, as a consequence of improvements in dyslipidasupply to the liver. emia,13 insulin resistance12 or fatty acid levels,14 or Using a stable isotope technique, we have previto reduction in adrenergic activity.5,27 The greater ously shown that the hepatic secretion of VLDL apoB is increased in viscerally obese subjects, unselected decrease in plasma free fatty acid levels with Df recently been shown to be very low.31 Hence, the potential cardiac complications associated with short-term use of Df in obese patients may be outweighed by improvements in endothelial function and cardiovascular risk factors,32 including plasma apoB levels.
In conclusion, this pilot study suggests that weight reduction with a hypocaloric diet alone or a hypocaloric diet plus Df potentially improves both the kinetics of VLDL apoB and endothelial function in visceral obesity. Our findings should be viewed as hypothesis-generating in respect of the greater beneficial effects of similar anorectic agents on these endpoints than diet alone. Whether there are specific metabolic and vascular benefits with newer, serotonergic agents (e.g. sibutramine) for treating obesity requires investigation with, as indicated above, a larger sample size than used in the present study. More weight loss may also be required to normalize endothelial dysfunction than dyslipoproteinaemia in obesity.
